- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- Industry news
- Intellectual Property
News of the day
Salix Commences Patent Infringement Litigation Against Novel Laboratories
RALEIGH, NC, May 14, 2008 - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that Salix Pharmaceuticals, Inc.; Norgine, B.V. and Norgine Europe, B. V. have filed a lawsuit in the United States District Court for the District of New Jersey against Novel Laboratories, Inc. for infringement of Norgine's patent protecting MOVIPREP® (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution). Norgine licensed MOVIPREP to Salix for... moreCanadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug
Toronto, ON (May 7, 2008) -- Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving triple combination AIDS drug "Apo Triavir". Apotex is the first company to provide this medicine to Africa under the provisions of the Canadian Access to Medicines Regime (CAMR). moreCanadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug
Toronto, ON (May 7, 2008) -- Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving triple combination AIDS drug "Apo Triavir". Apotex is the first company to provide this medicine to Africa under the provisions of the Canadian Access to Medicines Regime (CAMR). moreIndustry news search
Most Viewed News
- Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®
- Genta Receives Key Patent Related to Oral Gallium Compound G4544
- U.S. Patent Office Upholds StemCells, Inc.'s Patents In Reexamination Decisions
- AstraZeneca Settles US Nexium Patent Litigation with Ranbaxy
- Provectus Pharmaceuticals Receives Patent Allowance in the EU for PH-10 Dermatology Agent
- RSS Feed...
Recent news
To keep up to date with news from this category use our
VioQuest Pharmaceuticals Announces Issuance of U.S. Patent
BASKING RIDGE, N.J., May 7, 2008 - VioQuest Pharmaceuticals (OTCBB: VOQP) today announced that the United States Patent and Trademark Office has issued a patent for the company's investigational product candidate...
EPO Announces Symbicort® European COPD Use Patent Decision
May 6, 2008--AstraZeneca today announced that the European Patent Office (EPO) Technical Board of Appeal has made a final ruling that the European Combination patent covering the use of Symbicort® (formoterol and...
GORE Receives Approval from FDA for Unique Patent Foramen Ovale Stroke Study
May 05, 2008 (Flagstaff, Arizona) -- W. L. Gore & Associates (Gore) today announced that it has received approval from the US Food & Drug Administration (FDA) to proceed with the Gore REDUCE* Clinical Study. The Gore...
WIPO Panel Rules Boston Scientific Liberte® and TAXUS® Liberte® Stents Do Not Infringe Medinol Patents
NATICK, Mass., May 5 -- Boston Scientific Corporation (NYSE: BSX) announced today that a World Intellectual Property Organization (WIPO) arbitration panel has issued its ruling in an arbitration between the Company and...
P&G Sues J&J for Patent Infringement on Tooth-Whitening Strips
CINCINNATI, May 2, 2008 -- The Procter & Gamble Company (NYSE: PG) has filed a lawsuit against Johnson & Johnson and McNeil-PPC, Inc., the manufacturer and distributor of Listerine Whitening(R) Quick Dissolving Strips,...
Bovie Medical Corporation Acquires Technology, Patents And Assets From Boston Scientific For RF Resection Device
Melville, New York, May 1, 2008 - Bovie Medical Corporation (the "Company") (Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced it has signed an agreement with Boston Scientific...
Sepracor Announces Final Settlement of XOPENEX(R) Inhalation Solution Patent Infringement Litigation with Breath Limited
MARLBOROUGH, Mass.--May 1, 2008--Sepracor Inc. (Nasdaq: SEPR) today announced that it has entered into a Settlement and License Agreement with Breath Limited (Breath), an Arrow Group subsidiary, to resolve the patent...
Sepracor Inc. Reports First Quarter 2008 Results, Certain Strategic Initiatives and Settlement of XOPENEX(R) Patent Litigation with Breath Limited
MARLBOROUGH, Mass., May 01, 2008 -- Sepracor Inc. (Nasdaq: SEPR) today announced its consolidated financial results for the first quarter 2008.
U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent
NEW YORK--April 30, 2008--Pfizer Inc announced today that the U.S. Patent & Trademark Office has issued a communication notifying the company that it will confirm the patentability of the claims of Pfizer's '893 basic...
Nabi Biopharmaceuticals Prevails in Opposition Hearing for NicVAX Patent
ROCKVILLE, Md., April 30, 2008 -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that the European Patent Office (EPO) upheld the Company's European Patent No. EP 1,135,166 (Hapten Carrier Conjugates for Treating...
SENTILLION RECEIVES U.S. PATENT FOR ADMINISTERING CONTEXT MANAGEMENT SYSTEMS
ANDOVER, MA - April 30, 2008 - Sentillion, the company that created healthcare single sign-on (SSO), announced that it has been issued a U.S. patent (6,993,556) for its technology upon which system administration...
Apogee Reports Completion of In Vivo Proof-of-Concept Studies and Filing of U.S. Patent Application
NORWOOD, Mass. (April 30, 2008) -- Apogee Technology, Inc. (ATCS.OB) (the "Company"), which is developing PyraDerm(TM), a proprietary intradermal drug delivery system for vaccines and other pharmaceuticals, and...
ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform
April 30, 2008 -- Halifax, Nova Scotia - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, unveiled today its DepoVax(TM) platform, a novel depot vaccine delivery system used to increase the efficacy...
Benitec secures further rights to HIV Therapeutic
29 April 2008, Melbourne, Australia: Leading developer of RNA interference (RNAi)-based therapeutics Benitec Limited (ASX:BLT) has secured further intellectual property rights that underpin its HIV/AIDS lymphoma...
Redpoint Bio Corporation Receives U.S. Patent for Method of Identifying Activators of Key Ion Channel Involved in Taste Signaling
EWING, N.J., Apr 29, 2008 -- Redpoint Bio Corporation (OTCBB: RPBC), a company developing ingredients to improve the taste of pharmaceutical, food and beverage products, today announced the issuance of Patent No....
WEX Announces Successful Reexamination of Key Patent Covering Uses of Tectin
Vancouver, BC (April 29, 2008) - WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX: WXI) announced today that the U.S. Patent and Trademark Office has issued a Reexamination Certificate for United States Patent No....
Neuralstem Announces Issuance of Core Technology Patent in Europe
ROCKVILLE, Md., April 28, 2008 -- Stem cell company, Neuralstem, Inc., (Amex: CUR) announced today that the European Patent Office has granted Neuralstem a European patent EP0915968, covering the "Isolation, Propagation...
Elixir Pharmaceuticals Announces Issuance of SIRT Patent Covering Development of New Therapies Based on Breakthrough Science
Cambridge, MA - April 28, 2008 - Elixir Pharmaceuticals, Inc., announced today issuance of U.S. Patent No. 7,351,542, which covers the discovery of new and existing chemical entities that modulate the activity of a...
New Artificial Liver Tests: HepaLife's 'PICM-19' Demonstrate Advantages Over Today's Best-Available Liver Cells
Boston, MA - April 28, 2008 - HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625) today announced that results from new tests of the Company's patented PICM-19 liver cells show the highest levels of...
Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
REHOVOT, Israel and JERSEY CITY, New Jersey, April 28, 2008 -- Rosetta Genomics (Nasdaq: ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced today that it has signed a non-exclusive...
Spectranetics Reaches Settlement with Medtronic
COLORADO SPRINGS, Colo.--April 28, 2008--Spectranetics Corporation (Nasdaq:SPNC) today announced that it has settled its intellectual property dispute with Medtronic, and that Medtronic has taken a license to the patent...
Australian Patent Granted for 3D Display System
Vancouver, BC, April 24, 2008 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is pleased to announce that it has been granted acceptance by the Australian Commissioner of Patents for its Real-Time 3D2D Display...
Signalife Awarded New U.S. Patent, 'System For, And Method Of, Monitoring Heartbeats Of A Patient'
LOS ANGELES, Apr. 23, 2008 -- Signalife, Inc. (Amex: SGN - News) has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of,...
StemCells, Inc. Granted Key U.S. Patent Covering Composition of Neural Stem Cells Derived From Any Tissue Source, Including Embryonic
PALO ALTO, Calif. (April 23, 2008) - StemCells, Inc. (NASDAQ: STEM) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,361,505 with broad claims covering human neural stem cells...
Orqis(R) Medical Awarded 15th U.S. Patent
LAKE FOREST, Calif., April 23 -- Orqis(R) Medical Corporation, a medical products company developing and marketing devices to improve cardiac performance through Aortic Flow Therapy, announced today that the United...
VIRALYTICS USA PATENT ISSUED
April 23, 2008 - Viralytics Limited (VLA) advises that it has been granted a patent in the United States of America for the use of its family of 4 Coxsackie viruses for the treatment of all cancers bearing expression of...
NUCLEONICS SAYS USPTO REJECTS ALL CLAIMS FOR FOURTH TIME IN RE-EXAM OF BENITEC'S PATENT
HORSHAM, PA (April 22, 2008): Nucleonics, Inc., a biotechnology company focused on the development of novel expressed RNA interference-based (eiRNA) therapeutics, announced today that the U.S. Patent and Trademark...
RegeneRx Receives Ophthalmic Patent in Hong Kong
BETHESDA, Md.--April 22, 2008--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it has received official notice from the Hong Kong Intellectual Property Department granting a patent...
Microchip Biotechnologies, Inc. enters into license arrangement with GE Healthcare for fundamental microfluidic patents
April 22, 2008 - Microchip Biotechnologies, Inc. (MBI) announces that it has entered into a multi-patent license agreement with GE Healthcare that significantly enhances MBI's intellectual property portfolio supporting...
Meda has settled the U.S. Astelin® patent litigation with Apotex
April 21, 2008 -- Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Apotex Inc. and Apotex Corp. (hereafter Apotex) that resolves the U.S. patent...
ELRON ANNOUNCES THAT GIVEN IMAGING ANNOUNCES PATENT LITIGATION SETTLEMENT
Tel Aviv, April 21, 2008 - Elron Electronic Industries Ltd. (TASE & NASDAQ: ELRN), today announced that Given Imaging Ltd. (TASE & NASDAQ: GIVN), 18.3% held by Elron and 9.1% held through Elron's 50.1% subsidiary, RDC,...
Benitec US Patent Re-exam Update
April 21, 2008, Melbourne, Australia: The Directors of Benitec Limited (ASX: BLT) provide the following update on the USPTO patent re-examination and the recent examiner non-final response.
Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®
Leverkusen, April 21, 2008 - Bayer confirmed that Bayer Schering Pharma AG and Bayer HealthCare Pharmaceuticals Inc. filed a patent infringement lawsuit in U.S. Federal Court in the Southern District of New York (New...
10th PATENT AWARDED TO VIRTUALSCOPICS
ROCHESTER, NY - April 21, 2008 - VirtualScopics, Inc. (NASDAQ: VSCP), a leading developer of image-based biomarker solutions for the pharmaceutical, biotechnology and medical device industries, today announced it has...
St. Jude Medical Awarded U.S. Patent for Neurostimulation Therapy for Depression
ST. PAUL, Minn.--April 21, 2008--St. Jude Medical, Inc. (NYSE:STJ) today announced it has been awarded a patent from the U.S. Patent and Trademark Office for treating depression using neurostimulation therapy in an area...
Given Imaging Announces Patent Litigation Settlement
YOQNEAM, ISRAEL-- April 21, 2008 -- Given Imaging Ltd. (NasdaqGM: GIVN - News ) today announced that it has signed a term sheet with Olympus Corporation outlining a settlement of the patent litigation between the two...
St. Jude Medical Awarded U.S. Patent for Neurostimulation Therapy for Depression
ST. PAUL, Minn. - April 21, 2008 - St. Jude Medical, Inc. (NYSE:STJ) today announced it has been awarded a patent from the U.S. Patent and Trademark Office for treating depression using neurostimulation therapy in an...
U.S. Patent Office Allows Significant New VNUS Patent
SAN JOSE, Calif., April 18, 2008 -- VNUS® Medical Technologies, Inc. (Nasdaq: VNUS) today announced that the company has received a Notice of Allowability by the U.S. Patent & Trademark Office for a patent application...
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
DETROIT, April 18, 2008 -- Caraco Pharmaceutical Laboratories, Ltd. (Amex: CPD) has confirmed that the United States District Court of New Jersey has granted Caraco's motion for summary judgment that the claims of U.S....
Federal Court in Canada Upholds Pfizer's Norvasc Patent; Decision Prevents Launch of Generic Amlodipine Besylate Product by Pharmascience until 2010
NEW YORK--April 17, 2008--Pfizer Inc said today that the Canadian Federal Court has upheld a Pfizer patent covering amlodipine besylate, the active ingredient in Norvasc. The court issued an order prohibiting regulatory...
OraSure Technologies to Defend Patent Infringement Lawsuit
BETHLEHEM, Pa.--April 17, 2008--OraSure Technologies, Inc. (NASDAQ:OSUR) announced that it has received a complaint from Inverness Medical Innovations, Inc. (AMEX:IMA), Inverness Medical Switzerland GmbH and Church &...
Immersion Medical Files Patent Infringement Lawsuit Against Mentice AB, Mentice SA, Simbionix USA Corp., and Simbionix Ltd.
SAN JOSE, Calif., April 16, 2008 -- Immersion Corporation (NASDAQ:IMMR), a leading developer and licensor of touch feedback technology, announced today that its wholly owned subsidiary, Immersion Medical, Inc, filed a...
Bayer CropScience to enforce its Mefenpyr patent
Monheim, April 16, 2008 - Bayer CropScience recently filed a lawsuit against the Chinese company Jiangsu Tian Rong in an intermediate court in Jiang Su, to enforce rights under its Chinese Mefenpyr patent. The company...
Biophan Expands Intellectual Property Portfolio with Two New Patents
PITTSFORD, NY--April 16, 2008 -- Biophan Technologies, Inc. (OTC BB:BIPH.OB), a developer of next-generation biomedical technology, today announced the expansion of its intellectual property portfolio for development in...
RANBAXY AND ASTRAZENECA REACH AGREEMENT IN ESOMEPRAZOLE PATENT LITIGATION
Gurgaon, India; Princeton, NJ - April 15, 2008 -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that it has reached several agreements with...
RANBAXY AND ASTRAZENECA REACH AGREEMENT IN ESOMEPRAZOLE PATENT LITIGATION
Gurgaon, India; Princeton, NJ - April 15, 2008 - Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that it has reached several agreements with...
U.S. Patent Office Upholds StemCells, Inc.'s Patents In Reexamination Decisions
PALO ALTO, Calif., (April 15, 2008) - StemCells, Inc. (NASDAQ: STEM) announced today that the U.S. Patent and Trademark Office (PTO) has upheld two of the Company's neural stem cell patents, with only minor amendments,...
AstraZeneca Settles US Nexium Patent Litigation with Ranbaxy
April 15, 2008--AstraZeneca today announced it has entered into a settlement agreement in its Nexium patent infringement litigation against Ranbaxy Laboratories Ltd. and its affiliates ("Ranbaxy").
AdvaMed Statement on Patent Reform Legislation
WASHINGTON, D.C. - April 15, 2008 - Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), released the following statement today regarding Sen. Arlen Specter's (R-PA) position on...
Provectus Pharmaceuticals Receives Patent Allowance in the EU for PH-10 Dermatology Agent
KNOXVILLE, Tenn.--April 15, 2008--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has received allowance of its patent...
Starpharma's dendrimer SPL7013 found to have potential application for arthritis
Melbourne, Australia; 14 April 2008: Starpharma Holdings Ltd (ASX:SPL, OTCQX) has filed a patent application for the use of SPL7013, the active ingredient in VivaGel®, to inhibit hyaluronidase activity in the treatment...
Genta Receives Key Patent Related to Oral Gallium Compound G4544
BERKELEY HEIGHTS, NJ - April 14, 2008 - Genta Incorporated (NASDAQ: GNTA) today announced that the Company has received notice that its patent application covering novel pharmaceutical gallium compositions and complexes...
Medical Use Patent on NF B Decoy-Oligo Granted in Europe Covering Its Use for Atopic Dermatitis
April 7, 2008 We, AnGes MG, are pleased to announce that our medical use patent on NF-B decoy-oligo, for use in the treatment of atopic dermatitis, was granted in Europe, with the patent gazette (EP1362600B1) published...
Kamada Receives a European Patent for its AAT Manufacturing Process
Weizmann Science Park, Ness Ziona, Israel, April 6th, 2008. Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, announced today it has received a European...
Entelos Announces U.S. Patent for its Diabetes Model
Foster City, CA, April 3, 2008 - Entelos, Inc. (LSE:ENTL) a leading life sciences company building predictive computer models of human physiology and "virtual patients" for drug discovery and development, announced...
Codon Devices and Blue Heron Biotechnology announce Settlement of Dispute
Cambridge, MA and Bothell, WA - March 31, 2008 - Codon Devices, Inc., and Blue Heron Biotechnology, Inc., announced today that they have settled the dispute giving rise to the complaint filed by Codon Devices on March...
SOLBEC ANNOUNCES GRANT OF US PATENT
Perth, Australia. 28 March 2008: Solbec Pharmaceuticals (ASX: SBP) advises that the United States Patent and Trademark Office (USPTO) has granted a continuation of Solbec's key patent entitled: "Rhamnose Binding...
Russian Patent Granted for MAPD Solid-State Photo Detectors
VANCOUVER, BRITISH COLUMBIA--(- March 28, 2008) - Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I) today announced that it has been granted full patent rights for its latest Micro-channel Avalanche Photodiode...
QuantRx Announces Expansion of its Molecular Imaging Technology Platform for Development of Diagnosis and Treatment Agents for Alzheimer's Disease (AD)
Doylestown, PA, March 27, 2008 - QuantRx Biomedical Corporation, (OTCBB:QTXB), a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented...
OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNA's, Including Its Phase III Compound Bevasiranib
MIAMI, March 18, 2008 -- OPKO Health, Inc. (Amex: OPK) today announced that it has been issued a key patent by the United States Patent and Trademark Office (USPTO) for methods related to the use and administration of...
STUDY FINDS STARION INSTRUMENTS' TISSUE WELDING TECHNOLOGY SAFE AND EFFECTIVE IN PAROTIDECTOMY PROCEDURES
Sunnyvale, Calif. - March 4, 2008 - Starion Instruments, a leading surgical device company, today announced that a study published in the January 2008 issue of The American Surgeon found Starion's patented Tissue...
Patent Study Reveals Immersion's Innovation, Impact, and Leadership in Haptics Technology
SAN JOSE, Calif., February 26, 2008 -- Immersion Corporation (Nasdaq: IMMR), a leading developer and licensor of touch feedback technology (http://www.immersion.com/corporate/), announces that results of a study on...
NOVELOS THERAPEUTICS RECEIVES 5th U.S. PATENT
NEWTON, Mass., September 10, 2007 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos was issued...
NOVELOS THERAPEUTICS RECEIVES NOTICE OF ALLOWANCE FOR 5th U.S. PATENT
NEWTON, Mass., September 11, 2006 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the Company has...
TWO NEW PATENTS STRENGTHEN MEDENNIUM'S PORTFOLIO OF INNOVATIVE OPHTHALMIC PRODUCTS
IRVINE, CA.-September 1, 2001-Medennium, an emerging leader in ophthalmic implants and materials development, announced today the receipt of two new patents from the United States Patent Office.
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us